Home Issue Brief Content Type

View the Latest: Issue Brief

Filter

List Grid

951 - 960 of 2,164 Results

  • Consumer Assistance in Health Insurance: Evidence of Impact and Unmet Need

    Issue Brief

    The Affordable Care Act (ACA) established in-person consumer assistance programs to help people identify coverage options and enroll. A variety of professionals provide consumer assistance, including Navigator programs that are funded through state and federal marketplaces, brokers who receive commissions from insurers, local non-profit organizations, and health care providers. In the spring of 2020, KFF surveyed consumers most likely to use or benefit from consumer assistance to learn who uses consumer assistance, why they seek…

  • The Veterans Health Administration’s Role During the COVID-19 Response

    Issue Brief

    A new issue brief examines the role of the Veterans Health Administration (VHA) during the coronavirus pandemic, and public health emergencies more broadly. The analysis finds that the VHA has provided assistance to 46 states and D.C., including treating over 270 non-veteran patients with coronavirus.

  • Key Questions About Nursing Home Regulation and Oversight in the Wake of COVID-19

    Issue Brief

    The COVID-19 pandemic has led to renewed interest among policymakers, the media, residents, and their families in nursing home regulation and oversight, as residents and staff are at increased risk of infection due to the highly transmissible nature of the coronavirus, the congregate nature of facility settings, and the close contact that many workers have with patients. This issue brief answers key questions about nursing home oversight under Medicare and Medicaid and explains how federal…

  • The Critical Care Workforce and COVID-19: A State-by-State Analysis

    Issue Brief

    This data note quantifies the availability of providers capable of providing critical care in each state relative to state-level population. It finds that the number of intensivist physicians is substantially smaller than that of “second-line” providers that sometimes provide critical care, such as hospitalists, pulmonologists, and anesthesiologists, lending credence to longstanding concerns that intensivists are in short supply in the U.S. at baseline.

  • What Do We Know About Children and Coronavirus Transmission?

    Issue Brief

    As schools prepare for Fall, this brief examines what's known about children and COVID-19, including the risk the virus poses to children and the risk of children becoming infected and transmitting to others, and the experiences of other countries that reopened classrooms.

  • Rising Cases in Long-term Care Facilities Are Cause for Concern

    Issue Brief

    LTC cases in hotspot states are increasing at 4x the rate as LTC cases in non-hotspot states. Media has largely focused on the share of cases attributed to a younger population. However, increased cases in long-term care facilities are cause for concern, given that nearly half of all COVID-19 deaths have been in long-term care facilities. This piece provides state-level data, including data that shows that long-term care cases in Texas and Florida have increased…

  • Millions of Seniors Live In Households with School-Age Children

    Issue Brief

    About 3.3 million adults age 65 or older live in a household with school-age children, a factor that state and local officials may want to take into account when deciding when and how fully to re-open schools this fall, a new KFF analysis finds. These older adults, who represent roughly 6 percent of all seniors in the U.S., live with 4.1 million school age children, who comprise about seven percent of all kids ages 5…

  • How Could the Price of Remdesivir Impact Medicare Spending for COVID-19 Patients?

    Issue Brief

    This brief discusses how drugs provided in inpatient hospital settings are covered and reimbursed for beneficiaries in traditional Medicare under current law. This is relevant for Medicare spending on COVID-19 patients who receive Gilead’s new antiviral drug remdesivir. We discuss the implications for hospitals and the Medicare program of spending on remdesivir.